Recombinant lipoproteins: lipoprotein-like lipid particles for drug targeting

…, RLA de Vrueh, J Kuiper, MK Bijsterbosch… - Advanced drug delivery …, 2001 - Elsevier
Lipoproteins are endogenous particles that transport lipids through the blood to various cell
types, where they are recognised and taken up via specific receptors. These particles are, …

Selective liver targeting of antivirals by recombinant chylomicrons—a new therapeutic approach to hepatitis B

…, MCM Van Dijk, EC Havenaar, MK Bijsterbosch… - Nature medicine, 1995 - nature.com
Hepatitis B virus (HBV) infection is the world's most important chronic virus infection. No safe
and effective treatment is available at present, and clinical exploration of promising antiviral …

In vivo fate of phosphorothioate antisense oligodeoxynucleotides: predominant uptake by scavenger receptors on endothelial liver cells

MK Bijsterbosch, M Manoharan, ET Rump… - Nucleic acids …, 1997 - academic.oup.com
Systemically administered phosphorothioate antisense oligodeoxynucleotides can specifically
affect the expression of their target genes, which affords an exciting new strategy for …

Design and synthesis of novel amphiphilic dendritic galactosides for selective targeting of liposomes to the hepatic asialoglycoprotein receptor

…, PJ van Santbrink, MK Bijsterbosch… - Journal of Medicinal …, 1999 - ACS Publications
A series of glycolipids have been prepared which contain a cluster galactoside moiety with
high affinity for the hepatic asialoglycoprotein receptor and a bile acid ester moiety which …

Modulation of plasma protein binding and in vivo liver cell uptake of phosphorothioate oligodeoxynucleotides by cholesterol conjugation

MK Bijsterbosch, ET Rump, RLAD Vrueh… - Nucleic acids …, 2000 - academic.oup.com
Several studies have shown improved efficacy of cholesteryl-conjugated phosphorothioate
antisense oligodeoxynucleotides. To gain insight into the mechanisms of the improved …

Targeted delivery of oligodeoxynucleotides to parenchymal liver cells in vivo

…, J KUIPER, MK BIJSTERBOSCH… - Biochemical …, 1999 - portlandpress.com
Anti-sense oligodeoxynucleotides (ODNs) hold great promise for correcting the biosynthesis
of clinically relevant proteins. The potential of ODNs for modulating liver-specific genes …

Aorta of ApoE-deficient mice responds to atherogenic stimuli by a prelesional increase and subsequent decrease in the expression of antioxidant enzymes

…, M Van Eck, MK Bijsterbosch… - Circulation …, 2003 - Am Heart Assoc
… This article is dedicated to the memory of Martin Bijsterbosch, an active and respected
member of the scientific community, who passed away on May 9, 2003, at the age of 49. …

B lymphocyte receptors and polyphosphoinositide degradation

MK Bijsterbosch, CJ Meade, GA Turner, GGB Klaus - Cell, 1985 - cell.com
Resting B lymphocytes can be activated and induced to proliferate by antibodies against
their antigen receptors (anti-Ig). We demonstrate an early increase in the level of [3H]inositol …

Crosslinking of surface immunoglobulin and Fc receptors on B lymphocytes inhibits stimulation of inositol phospholipid breakdown via the antigen receptors.

MK Bijsterbosch, GG Klaus - The Journal of experimental medicine, 1985 - rupress.org
F(ab')2 fragments of rabbit anti-mouse Ig induce proliferation of murine B lymphocytes, whereas
the intact antibodies are not mitogenic. F(ab')2 anti-Ig stimulates the rapid breakdown of …

[HTML][HTML] Lactoferrin uptake by the rat liver. Characterization of the recognition site and effect of selective modification of arginine residues.

GJ Ziere, MC Van Dijk, MK Bijsterbosch… - Journal of Biological …, 1992 - Elsevier
Recently it was found that lactoferrin, an iron-binding glycoprotein with a molecular weight
of 76,500, inhibits the remnant receptor-mediated uptake of apolipoprotein E (apoE)-bearing …